The issue of obesity has become a pressing concern in the United States, with approximately 40% of adults and nearly 20% of children suffering from the condition. The Trump administration's nominee for Secretary of Health, Robert Kennedy Jr., has proposed tackling obesity through lifestyle changes, healthy eating, and exercise. However, Elon Musk, a close ally of the president, has advocates for the use of injectable medications like Ozempic and Wegovy, produced by Novo Nordisk, to facilitate the widespread availability of GLP-1 receptor agonists at a low cost. Kennedy has criticized the pharmaceutical industry for profiting from Americans' ''stupidity'' and ''dependence'' on such medications.